Inhalation Sciences names Pontus Nobréus CEO, replacing Manoush Masarrat

• Inhalation Sciences Sweden AB named Pontus Nobréus CEO, effective Oct. 5, 2026, replacing Manoush Masarrat at his request.
• Nobréus previously served as CEO of Redsense Medical and Pro Health Pharma Sweden, with international leadership experience in medtech and life sciences.
• Masarrat will remain with the company until year-end to support the management transition.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inhalation Sciences Sweden AB published the original content used to generate this news brief on September 22, 2026, and is solely responsible for the information contained therein.